Breaking News

Theorem Expands Cardio Capabilities

By Kristin Brooks | January 7, 2014

Forms strategic alliance with BioTelemetry division

Theorem Clinical Research has entered a strategic alliance with BioTelemetry, Inc. and its clinical research division Cardiocore, a global cardiac core lab. Financial terms of the pact were not disclosed.
 
Discussing the alliance, John Potthoff, Theorem president and chief executive officer, remarked, “Theorem’s business strategy is to offer our clients the very best in every service area. BioTelemetry reinforces that strategy with a team of industry-leading scientists, a set of advanced technologies and a broad base of cardiac testing modalities. Theorem clients will benefit from BioTelemetry’s expert consulting services and deep experience across all major therapeutic areas.”
 
BioTelemetry’s chief executive officer, Joseph Capper, said, “Theorem’s experience in complex protocols aligns perfectly with our specialized cardiovascular testing services. The partnership complements BioTelemetry’s unique position that spans from clinical research through post-market surveillance and into clinical practice.  Both companies support trials in all clinical phases of pharmaceutical and biotech development and will collaborate globally within this alliance.”
blog comments powered by Disqus
  • Quality Risk Management

    Quality Risk Management

    Cheryl Abernathy and Bryan Sasbon, Quality Assurance Operations Manager, Ropack Pharma Solutions; QA Director & Regulatory Affairs, Ropack Pharma Solutions||September 8, 2016
    Embracing the process as a means to a strong quality culture

  • Staying Ahead in the Small Molecule Space

    Staying Ahead in the Small Molecule Space

    Dr. Matthew Moorcroft, VP Global Marketing, Cambrex||September 8, 2016
    Understand what is happening in the market and react accordingly

  • FDA & Drug Development

    FDA & Drug Development

    Rachelle Du2019Souza, Regulatory Heights Inc.||September 8, 2016
    You must perform the necessary due diligence to stay on top of regulatory developments